Inventor · disambiguated record
Mika Lindvall
Also filed as: LINDVALL MIKA · LINDVALL MIKA K · LINDVALL MIKA KRISTIAN
19 granted patents·13 pending applications·164 citations·filing 2003–2020
94Inventor score
Top patents by PatentIndex Score
32 records- 0195US8168794B2Pim kinase inhibitors and methods of their useBURGER MATTHEW·Filed 2009·Granted May 1, 2012·36 cites·14 claims
- 0291US7709497B2Pyrazolo[3,4-b]pyridine compound, and its use as a PDE4 inhibitorGLAXO GROUP LTD·Filed 2005·Granted May 4, 2010·28 cites·13 claims
- 0390US7553854B26-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signalingNOVARTIS VACCINES & DIAGNOSTIC·Filed 2007·Granted Jun 30, 2009·20 cites·78 claims
- 0489US8822497B2PIM kinase inhibitors and methods of their useBURGER MATTHEW·Filed 2008·Granted Sep 2, 2014·10 cites·9 claims
- 0587US8829193B2PIM kinase inhibitors and methods of their useBURGER MATTHEW·Filed 2012·Granted Sep 9, 2014·5 cites·11 claims
- 0686US8710048B26-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signalingSUTTON JAMES C·Filed 2012·Granted Apr 29, 2014·12 cites·28 claims
- 0783US10188649B2Aminoheteroaryl benzamides as kinase inhibitorsNOVARTIS AG·Filed 2017·Granted Jan 29, 2019·3 cites·4 claims
- 0882US10369138B2Monobactam organic compounds for the treatment of bacterial infectionsNOVARTIS AG·Filed 2015·Granted Aug 6, 2019·3 cites·17 claims
- 0981US9174978B2Monobactam organic compounds for the treatment of bacterial infectionsAULAKH VIRENDER SINGH·Filed 2015·Granted Nov 3, 2015·5 cites·24 claims
- 1081US8735424B2Bicyclic kinase inhibitorsBURGER MATTHEW·Filed 2009·Granted May 27, 2014·5 cites·17 claims
- 1180US9763937B2Aminoheteroaryl benzamides as kinase inhibitorsBAGDANOFF JEFFREY T·Filed 2015·Granted Sep 19, 2017·3 cites·4 claims
- 1280US9242996B2Aminoheteroaryl benzamides as kinase inhibitorsBAGDANOFF JEFFREY T·Filed 2014·Granted Jan 26, 2016·5 cites·27 claims
- 1379US7566786B2Quinoline derivatives as phosphodiesterase inhibitorsGLAXO GROUP LTD·Filed 2004·Granted Jul 28, 2009·14 cites·23 claims
- 1478US7528148B2Pyrazolo[3,4-B]pyridine compounds, and their use as phosphodiesterase inhibitorsGLAXO GROUP LTD·Filed 2003·Granted May 5, 2009·14 cites·52 claims
- 1570US7465743B2Pyrazolo[3,4-b]pyridine compounds, and their use as PDE4 inhibitorsGLAXO GROUP LTD·Filed 2005·Granted Dec 16, 2008·1 cites·24 claims
- 1667US10660888B2Aminoheteroaryl benzamides as kinase inhibitorsNOVARTIS AG·Filed 2018·Granted May 26, 2020·0 cites·6 claims
- 1764US2020276169A1Monobactam organic compounds for the treatment of bacterial infectionsNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1861US2019231752A1Monobactam organic compounds for the treatment of bacterial infectionsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1960US2009312325A1Quinoline Derivatives As Phosphodiesterase InhibitorsBALDWIN IAN ROBERT·Filed 2009·Application pending·0 cites
- 2056US2008132536A1Pyrazolo [3,4-b] pyridine compounds, and their use as pde4 inhibitorsGLAXO GROUP LTD·Filed 2008·Application pending·0 cites
- 2155US2008175914A1Pyrazolo[3,4-b]Pyridine Compounds, and their Use as Phosphodiesterase InhibitorsGLAXO GROUP LTD·Filed 2008·Application pending·0 cites
- 2251US2014249135A1Pim kinase inhibitors and methods of their useBURGER MATTHEW·Filed 2014·Application pending·0 cites
- 2351US2009131431A1Pyrazolo[3,4-b]pyridine compounds, and their use as a PDE4 inhibitorsEDLIN CHRISTOPHER DAVID·Filed 2006·Application pending·0 cites
- 2449US2006089375A1Pyrazolo[3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitorsALLEN DAVID G·Filed 2003·Application pending·0 cites
- 2549US2007293491A1Indazole compounds and methods for inhibition of cdc7NOVARTIS VACCINES & DIAGNOSTIC·Filed 2007·Application pending·0 cites
- 2645US2020407365A1Indole-2-carbonyl compounds and their use for the treatment of hepatitis bNOVARTIS AG·Filed 2019·Application pending·0 cites
- 2743US10919887B2Salts and solid forms of a monobactam antibioticNOVARTIS AG·Filed 2016·Granted Feb 16, 2021·0 cites·9 claims
- 2843US2021079015A1Novel dihydroisoxazole compounds and their use for the treatment of hepatitis bNOVARTIS AG·Filed 2018·Application pending·0 cites
- 2941US9546173B2Substituted pyrrolo[3,4-d]pyrimidines as kinase inhibitorsDILLON MICHAEL PATRICK·Filed 2013·Granted Jan 17, 2017·0 cites·17 claims
- 3041US2008021058A1Pyrazolo '3,4-B! Pyridine Compounds And Their Use As Phosphodiesterase Type 4(Pde4) InhibitorsALLEN DAVID G·Filed 2005·Application pending·0 cites
- 3137US11160797B2Pyridinone derivatives and their use as selective ALK-2 inhibitorsNOVARTIS AG·Filed 2017·Granted Nov 2, 2021·0 cites·18 claims
- 3237US2013109682A1Cyclic ether compounds useful as kinase inhibitorsBURGER MATTHEW·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →